Eat Away Pulmonary Fibrosis Scar Tissue

Pulmonary Fibrosis literally means lung (pulmonary) scarring (fibrosis). The lung scarring occurs in the tissue of the lung called the interstitium, which supports the structures of the lung (air sacs/alveoli). There are an estimated 130-200 related diseases called Interstitial Lung Disease that are similar in characteristics and can result in scarring. Pulmonary Fibrosis causes the lung tissue to thicken and become stiff. Scarring inhibits oxygen from entering the blood stream.
Idiopathic Pulmonary Fibrosis
When the cause of  Pulmonary Fibrosis is unknown it is called "idiopathic, " or Idiopathic Pulmonary Fibrosis. IPF is the most common form of Interstitial Lung Disease. Below is a summary of the prevalence of the disease:
The actual incidence is unknown.
It is estimated that 50,000 new cases are diagnosed annually.
More than 200,000 people in the United States suffer from this disease.
There are at least 5,000,000 cases world wide.
It affects both men and women, with a slightly higher incidence in men.
The average onset age is 40-70 but the disease can occur at any age.
Although uncommon, IPF does occur in children and as young as 3 years of age. Interstitial Lung Disease has been diagnosed in children less than one year of age.
At least forty thousand individuals die from this disease each year.
The number of new cases of Pulmonary Fibrosis has dramatically increased in recent years. This is primarily due to improved diagnostic procedures.
IPF has no specific geographical distribution; it is found in equal proportions in urban and rural environments. A history of smoking has been associated with an increased risk of Idiopathic Pulmonary Fibrosis.
The disease varies from person to person. For some, the disease progresses slowly and gradually over months or years while for others there is a rapid progression. For others, it may stabilize for a period of time. The course is generally unpredictable.
William Wong N.D., Ph.D.
Member World Sports Medicine Hall of Fame.
Anti Fibrosis
Enzymes eat scar tissue and fibrosis. Fibrosis is scar tissue and most doctors learn in anatomy that it is fibrosis that eventually kills us all. Let me explain. As we age, which starts at 27, we have a diminishing of the body's output of enzymes. This is because we make a finite amount of enzymes in a lifetime and we use up a good deal of them by the time we reach our 40's (Cystic Fibrosis patients who have virtually no enzyme production to speak of, even as children usually don't make it past their 20's before they die of the restriction and shrinkage in the lungs from the formation of fibrosis or scar tissue).
So our body begins to dole out our enzymes with an eyedropper instead of with a tablespoon. Result: the repair mechanism of the body goes off balance and has nothing to reduce the over abundance of fibrin it deposits in nearly everything from simple cuts, to the inside of our internal organs and blood vessels. It is then when most women begin to develop things like fibrocystic breast disease, uterine fibroids, and endometriosis. We all grow arterial sclerotic (meaning scar tissue) plaque, and have fibrin begin to spider web its way inside of our internal organs, reducing their size and function over time. This is why as we age our wounds heal with thicker, less pliable, weaker and very visible scars.
If we replace the lost enzymes, we can control and reduce the amount of scar tissue and fibrosis our bodies have. As physicians in the US are now discovering, even old scar tissue can be "eaten away" from surgical wounds, pulmonary fibrosis, and kidney fibrosis even colloid years after their formation. Medical doctors in Europe and Asia have known this and used orally administered enzymes for such for over 40 years!
Pulmonary Fibrosis Question
"Seeking advice for a dear friend that has pulmonary fibrosis and is currently using Vitalzym. He shared with me last week that his latest test showed his heart function was up from 35% to 40%. Would Neprinol be more productive for him? And if so can you share with me the benefits that it would bring him. Many thanks N."
The heart normally beats between 60 and 100 times per minute, with many normal variations. For example, athletes at rest have slower heart rates than most people. The normal delay between the contraction of the atria and of the ventricles is 0.12 to 0.20 seconds. Pulmonary fibrosis causes an inflammation and scarring of the air sacs called alveoli, in the lungs. This reduces the ability of the lungs to transfer oxygen. The resulting lack of oxygen in the blood (hypoxemia) may cause increases in the pressure inside the blood vessels of the lungs, a situation known as pulmonary hypertension. The high blood pressure in the lungs then puts a strain on the right ventricle, the lower right side of the heart, which pumps the oxygen-poor blood into the lungs.
In my opinion the situation may be getting worse. Vitalzym may have slowed the condition, but increased heart function may be an indication that the heart is having to work harder to transfer blood and oxygen throughout the body. Neprinol unlike Vitalzym lessens the viscosity of blood by carrying the active enzyme Nattokinase. Nattokinase reduces the blood viscosity and cleans the blood reducing stress on the heart. In addition Nattokinase is one of the best enzymes to remove scar tissue. Serrapeptase is also a very good scar tissue removing enzyme. Nattokinase and Serrapeptase work independently in two distinct ways to remove scar tissue from the body. This synergistic effect coupled with the fact the Vitalzym is not nearly as concentrated as Neprinol conveys a clear choice for fibrosis patients. Vitalzym will work in less extreme cases but requires many times the dosage and the supplementation of VitalzymSEB to get the potency of just one bottle of Neprinol.
"What oxygen is to the lungs, such is hope to the meaning of life."- Emil Brunner
NEPRINOL is composed of Pharmaceutical-grade ingredients, provided exclusively through licensed healthcare practitioners and supplementation outlet stores. NEPRINOL?is 100% natural and contains no animal derivatives it is available now without a prescription.
Neprinol is safe to use with all supplements and all prescription medication except for prescription blood-thinners and anticoagulants such as Coumadin and Heparin.
Reduce scar tissue buildup and fibrosis with Neprinol.
We also highly recommend SerraEzyme and Clear Lungs Extra Strength for the treatment of fibrosis and scar tissue to be used in combination with Neprinol.
-----------------------------------------------------------------
SerraEzyme 80,000IU产品说明：

This NEW Quad-Strength Serrapeptase capsule (90 per bottle) has been specifically designed for those who require very high dosages, or for those who wish to take less capsules to achieve their desired dosage to better suit their lifestyle and/or finances. Suitable for vegetarians and vegans.

SerraEzyme is twice the strength of Serralone per capsule and is also Enteric Coated.
Details:
Note: We highly recommend Serrapeptase be taken in conjunction with Neprinol for the two conditions listed below.
How Serrapeptase helps Pulmonary Fibrosis and other lung conditions- Serrapeptase helps immensely as it clears out all of the inflammation, mucus and dead/scar tissue. By clearing away this problem tissue it enables the bodies own healing system to replace it with healthy tissue and better lung function as a result.
How Serrapeptase helps Internal/External Scar Tissue and Adhesions- Serrapeptase helps immensely as it slowly digests all of the dead tissue/scar tissue. By clearing away this problem tissue it enables the body's own healing system to replace it with healthy tissue.
Dosage:
Therapeutic Level: 1-3 capsules 3 times per day on an empty stomach.
Maintenance Level: 1 capsule 2 times per day on an empty stomach.
Children and Animals: A recommended dose of 1 capsule per day for children or small animals.  The dose can be increased for larger dogs or horses.

Supplement Facts
Serving Size: 1 capsule
Serving Per Container: 90
Amount Per Serving Information
Ingredient	Amount per serving	%Daily Value
Serrapeptase	80,000 IU	*
*Daily Value not established
Other Ingredients: rice flour, HPMCP enteric coating

--------------------------------------------------------------
注：该产品为美国BIOMEDIC LABS公司生产的保健品
------------------------------------------------------
本站声明：该产品为美国BIOMEDIC LABS公司生产的保健品，并由美国BIOMEDIC LABS公司声称可以改善或降低非纤维化症状。本站不对该产品的效果或对在此转载的说明文字负责。请患者务必遵医治疗，以免延误病情。以下为美国BIOMEDIC LABS公司的原文说明，仅供作为保健品使用的参考。

--------------------------------------------------------------
原产地英文商品名:
Serralone 120,000SU x 90Capsules
原产地英文药品名:
Serralone
中文参考商品译名:
Serralone 120,000SU x90胶囊
中文参考药品译名:
Serralone
生产厂家中文参考译名:
美国BIOMEDIC LABS公司
生产厂家英文名:
BIOMEDIC LABS

--------------------------------------------------------------
原产地英文商品名:
Serralone 120,000SU x 120Capsules
原产地英文药品名:
Serralone
中文参考商品译名:
Serralone 120,000SU x120胶囊
中文参考药品译名:
Serralone
生产厂家中文参考译名:
美国BIOMEDIC LABS公司
生产厂家英文名:
BIOMEDIC LABS

--------------------------------------------------------------
原产地英文商品名:
SerraEzyme 80,000IU x 90Capsules
原产地英文药品名:
SerraEzyme
中文参考商品译名:
SerraEzyme 80,000国际单位x90胶囊
中文参考药品译名:
SerraEzyme
生产厂家中文参考译名:
美国BIOMEDIC LABS公司
生产厂家英文名:
BIOMEDIC LABS